A 1H NMR-Based Metabonomic Investigation of Time-Related Metabolic Trajectories of the Plasma, Urine and Liver Extracts of Hyperlipidemic Hamsters

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Jiang, Chun ying ^a   Yang, Kang min ^a   Yang, Liu ^a   Miao, Zhao xia ^a   Wang, Ying hong ^a   Zhu, Hai bo ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETIC ACID; ACETOACETIC ACID; ALANINE; ASPARTIC ACID; BETAINE; CHOLINE; CITRIC ACID; CREATINE; CREATININE; CYTOSINE; DIMETHYLAMINE; DIMETHYLGLYCINE; GALACTOSE; GLUCOSE; GLUTAMINE; GLYCEROL; HIPPURIC ACID; HYPOXANTHINE; INOSINE; ISOBUTYRIC ACID; LIVER EXTRACT; LYSINE; METHIONINE; PYRUVIC ACID; SUCCINIC ACID; TAURINE; TYROSINE; UREA;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; HYPERLIPIDEMIA; INFLAMMATION; LIPID METABOLISM; MALE; METABOLISM; METABOLITE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PLASMA; PROTON NUCLEAR MAGNETIC RESONANCE; URINALYSIS; URINE; ANIMAL; BLOOD; CHEMISTRY; DIAGNOSTIC IMAGING; DIET; HAMSTER; LIVER; METABOLOMICS; PATHOLOGY;

CRICETINAE;

ANIMALS; BLOOD CHEMICAL ANALYSIS; CRICETINAE; DIET; HYPERLIPIDEMIAS; LIVER; METABOLOMICS; URINE;

EID: 84879467050     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066786     Document Type: Article

References (56)

1. Simons LA, (2002) Additive effect of plant sterol-ester margarine and cerivastatin in lowering low-density lipoprotein cholesterol in primary hypercholesterolemia. The American Journal of Cardiology 90: 737-740.
2. Mäkinen VP, Soininen P, Forsblom C, Parkkonen M, Inqman P, et al. (2008) 1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death. Mol Syst Biol 4: 167-78.
3. Zhang XY, Wang YL, Hao FH, Zhou XH, Han XY, et al. (2009) Human serum metabonomic analysis reveals progression axes for glucose intolerance and insulin resistance statuses. J Proteome Res 8: 5188-5195.
4. Peng JB, Jia HM, Xu T, Liu YT,? Zhang HW, et al. (2011) A 1H NMR based metabonomics approach to progression of coronary atherosclerosis in a rabbit model. Process Biochemistry 46: 2240-2247.
5. Zhang F, Jia Z, Gao P, Kong H, Li X, et al. (2009) Metabonomics study of atherosclerosis rats by ultra fast liquid chromatography coupled with ion traptime of flight mass spectrometry. Talanta 79: 836-44.
6. Zha W, A J, Wang G, Yan B, Gu S, et al. (2009) Metabonomic characterization of early atherosclerosis in hamsters with induced cholesterol. Biomarkers 14: 372-80.
7. Martin JC, Canlet C, Delplanque B, Agnani G, Lairon D, et al. (2009) 1H NMR metabonomics can differentiate the early atherogenic effect of dairy products in hyperlipidemic hamsters. Atherosclerosis 206: 127-33.
8. Carr TP, Krogstrand KL, Schlegel VL, Fernandez ML, (2009) Stearate-enriched plant sterol esters lower serum LDL cholesterol concentration in normo- and hypercholesterolemic adults. J Nutr 139: 1445-50.
9. Bertram HC, Malmendal A, Nielsen NC, Straadt IK, Larsen T, et al. (2009) NMR-based metabonomics reveals that plasma betaine increases upon intake of high-fiber rye buns in hypercholesterolemic pigs. Mol Nutr Food Res 53: 1055-62.
10. Sun Y, Lian Z, Jiang C, Wang Y, Zhu H, (2012) Beneficial metabolic effects of 29,39,59-tri-acetyl-N6- (3-Hydroxylaniline) adenosine in the liver and plasma of hyperlipidemic hamsters. PLoS ONE 7: e32115.
11. Schicho R, Shaykhutdinov R, Ngo J, Nazyrova A, Schneider C, et al. (2012) Quantitative metabolomic profiling of serum, plasma, and urine by 1H NMR spectroscopy discriminates between patients with Inflammatory bowel disease and healthy individuals. J Proteome Res 11: 3344-3357.
12. Atherton HJ, Bailey NJ, Zhang W, Taylor J, Major H, et al. (2006) A combined 1H-NMR spectroscopy- and mass spectrometry-based metabolomic study of the PPAR-alpha null mutant mouse defines profound systemic changes in metabolism linked to the metabolic syndrome. Physiol Genomics. 27: 178-86.
13. Beckonert O, Keun HC, Ebbels TM, Bundy J, Holmes E, et al. (2007) Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc 2: 2692-2703.
14. Wu D, Chen A, Johnson CS, (1995) An improved diffusion-ordered spectroscopy experiment incorporating bipolar-gradient pulses. J Magn Reson 115: 260-264.
15. Beckwith-Hall BM, Thompson NA, Nicholson JK, Lindon JC, Holmes E, (2003) A metabonomic investigation of hepatotoxicity using diffusion-edited 1H NMR spectroscopy of blood serum. Analyst 128: 814-818.
16. Trygg J, Wold S, (2002) Orthogonal projections to latent structures(O-PLS). J Chemometr 16: 119-128.
17. Cloarec O, Dumas ME, Trygg J, Craig A, Barton RH, et al. (2005) Evaluation of the orthogonal projection on latent structure model limitations caused by chemical shift variability and improved visualization of biomarker changes in 1H NMR spectroscopic metabonomic studies. Anal Chem 77: 517-526.
18. Trygg J, Holmes E, Lundstedt T, (2007) Chemometrics in metabonomics. J Proteome Res 6: 469-479.
19. Fan TWM, Lane AN, (2008) Structure-based profiling of metabolites and iotopomers by NMR. Prog. Nucl. Magn. Reson. Spectrosc. 52: 69-117.
20. Vinaixa M, Rodriguez MA, Rull A, Beltrán R, Bladé C, et al. (2010) Metabolomic assessment of the effect of dietary cholesterol in the progressive development of fatty liver disease. J Proteome Res. 9: 2527-38.
21. Valeille K, Ferezou J, Amsler G, Quignard-Boulangé A, Parquet M, et al. (2005) A cis-9,trans-11-conjugated linoleic acid richoil reduces the outcome of atherogenic process in hyperlipidemic hamster. Am J Physiol Heart Circ Physiol 289: H652-9.
22. Duarte IF, Goodfellow BJ, Barros A, Jones JG, Barosa C, et al. (2007) Metabolic characterisation of plasma in juveniles with glycogen storage disease type 1a (GSD1a) by high-resolution 1H NMR spectroscopy. NMR Biomed 20: 401-412.
23. Liu M, Tang H, Nicholson JK, Lindon JC, (2002) Use of 1H NMR determined diffusion coefficients to characterize lipoprotein fractions in human blood plasma. Magn Reson Chem 40: S83-S88.
24. Willker W, Leibfritz D, (1998) Assignment of mono- and polyunsaturated fatty acids in lipids of tissues and body fluids. Magn Reson Chem 36: S79-S84.
25. Villas-Bôas SG, Mas S, Akesson M, Smedsgaard J, Nielsen J, (2005) Mass spectrometry in metabolome analysis. Mass Spectrom Rev 24: 613-46.
26. Schrauwen P, Wagenmakers AJ, van Marken Lichtenbelt WD, Saris WH, Westerterp KR, (2000) Increase in fat oxidation on a high-fat diet is accompanied by an increase in triglyceride-derived fatty acid oxidation. Diabetes 49: 640-646.
27. Murray KN, Chaykin S, (1966) The reduction of nicotinamide N-oxide by xanthine oxidase. J Biol Chem 241: 3468-3473.
28. Barron JT, Barany M, Gu L, Parrillo JE, (1998) Metabolic fate of glucose in vascular smooth muscle during contraction induced by noradrenaline. J Mol Cell Cardiol 30: 709-19.
29. Sun YJ, Wang HP, Liang YJ, Yang L, Li W, et al. (2012) An NMR-based metabonomic investigation of the subacute effects of melamine in rats. J Proteome Res 11: 2544-2550.
30. Kalhan SC, Guo L, Edmison J, Dasarathy S, McCullough AJ, et al. (2011) Plasma metabolomic profile in nonalcoholic fatty liver disease. Metabolism 60: 404-13.
31. Mallin K, McCann K, D'Aloisio A, Freels S, Piorkowski J, et al. (2004) Cohort mortality study of capacitor manufacturing workers, 1944-2000. J Occup Environ Med. 46(6): 565-76.
32. Barr J, Vazquez-Chantada M, Alonso C, Perez-Cormenzana M, Mayo R, et al. (2010) Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease. J. Proteome Res. 9: 4501-12.
33. Nicholson JK, Connelly J, Lindon JC, Holmes E, (2002) Metabonomics: a platform for studying drug toxicity and gene function. Nat. Rev. Drug Discov. 1: 153-161.
34. Toborek M, Kopieczna GE, Drozdz M, Wieczorek M, (1995) Increased lipid peroxidation as a mechanism of methionine-induced atherosclerosis in rabbits. Atherosclerosis 115: 217-24.
35. Wang H, Tan H, Yang F, (2005) Mechanisms in homocysteineinduced vascular disease. Drug Discovery Today 2: 25-31.
36. Hanne CB, Lotte BL, Chen X, Per BJ, (2012) Impact of high-fat and high-carbohydrate diets on liver metabolism studied in a rat model with a systems biology approach. J Agric.Food Chem 60: 676-684.
37. Ahmed N, Thornalley PJ, (2002) Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl- carbamate and intrinsic fluorescence. Biochem J 364: 15-24.
38. Oorni K, Pentikainen MO, Annila A, Kovanen PT, (1997) Oxidation of low density lipoprotein particles decreases their ability to bind to human aortic proteoglycans. Dependence on oxidative modification of the lysine residues. J Biol Chem 272: 21303-11.
39. Hlais S, Reslan DR, Sarieddine HK, Nasreddine L, Taan G, et al. (2012) Effect of lysine, vitamin B(6), and carnitine supplementation on the lipid profile of male patients with hypertriglyceridemia: a 12-week, open-label, randomized, placebo-controlled trial. Clin Ther 34: 1674-82.
40. Melis GC, ter Wengel N, Boelens PG, van Leeuwen PA, (2004) Glutamine: recent developments in research on the clinical significance of glutamine. Curr Opin Clin Nutr Metab Care 7: 59-70.
41. Poeze M, Luiking YC, Breedveld P, Manders S, Deutz NE, (2008) Decreased plasma glutamate in early phases of septic shock with acute liver dysfunction is an independent predictor of survival. Clin Nutr 27: 523-30.
42. al-Waiz M, Mikov M, Mitchell SC, Smith RL, (1992) The exogenous origin of trimethylamine in the mouse. Metabolism 41: 135-6.
43. Rebouche CJ, Seim H, (1998) Carnitine metabolism and its regulation in microorganisms and mammals. Annu Rev Nutr 18: 39-61.
44. Kim IY, Jung J, Jang M, Ahn YG, Shin JH, et al. (2010) 1H NMR-based metabolomic study on resistance to diet-induced obesity in AHNAK knock-out mice. Biochem Biophys Res Commun 403: 428-434.
45. Holmes E, Li JV, Athanasiou T, Ashrafian H, Nicholson JK, (2011) Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. Trends Microbiol 19: 349-359.
46. Jung JY, Kim IY, Kim YN, Kim JS, Shin JH, et al. (2012) 1H NMR-based metabolite profiling of diet-induced obesity in a mouse mode. BMB Report 45: 419-24.
47. Williams HR, Cox IJ, Walker DG, North BV, Patel VM, et al. (2009) Characterization of inflammatory bowel disease with urinary metabolic profiling. Am J Gastroenterol 104: 1435-1444.
48. Chen SW, Chen YX, Shi J, Lin Y, Xie WF, (2006) The restorative effect of taurine on experimental nonalcoholic steatohepatitis. Dig Dis Sci 51: 2225-34.
49. Murakami S, Kondo-Ohta Y, Tomisawa K, (1999) Improvement in cholesterol metabolism in mice given chronic treatment of taurine and fed a high-fat diet. Life Sci 64: 83-91.
50. Vinaixa M, Rodriguez MA, Rull A, Beltrán R, Bladé C, et al. (2010) Metabolomic assessment of the effect of dietary cholesterol in theprogressive development of fatty liver disease. Journal of Proteome Research 9: 2527-2538.
51. Rull A, Vinaixa M, Ángel Rodriguez M, Beltrán R, Brezmes J, et al. (2009) Metabolic phenotyping of genetically modified mice: An NMR metabonomic approach. Biochimie 91: 1053-1057.
52. Jiang L, Huang J, Wang Y, Tang H, (2012) Metabonomic Analysis Reveals the CCl4-Induced Systems Alterations for Multiple Rat Organs. J Proteome Res 11: 3848-3859.
53. Bell JD, Brown JC, Nicholson JK, Sadler PJ, (1987) Assignment of resonances for 'acutephase' glycoproteins in high resolution proton NMR spectra of human blood plasma. FEBS Lett 215: 311-5.
54. Pepys MB, (2005) CRP or not CRP? That is the question. Arterioscler Thromb Vasc Biol 25: 1091-4.
55. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, et al. (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114: 1752-1761.
56. Seidel A, Brunner S, Seidel P, Fritz GI, Herbarth O, (2006) Modified nucleosides: an accurate tumour marker for clinical diagnosis of cancer, early detection and therapy control. Br J Cancer 94: 1726-33.